IP Library Granted Patent US 8,445,692
Granted Patent B2
US 8,445,692 · App. 13/289,821 · Granted May 21, 2013

Compounds that inhibit (block) bitter taste in composition and use thereof

Inventors: Donald S Karanewsky (Escondido, CA); Joseph R. Fotsing (San Diego, CA); Catherine Tachdjian (San Diego, CA); Melissa Arellano (San Diego, CA)
Assignee: Senomyx Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,445,692
App. No.
13/289,821
Granted
May 21, 2013
Kind
B2
Abstract

The present invention relates to the discovery that specific human taste receptors in the T2R taste receptor family respond to particular bitter compounds present in, e.g., coffee. Also, the invention relates to the discovery of specific compounds and compositions containing that function as bitter taste blockers and the use thereof as bitter taste blockers or flavor modulators in, e.g., coffee and coffee flavored foods, beverages and medicaments. Also, the present invention relates to the discovery of a compound that antagonizes numerous different human T2Rs and the use thereof in assays and as a bitter taste blocker in compositions for ingestion by humans and animals.

Claims (70)

1. A method of reducing or alleviating bitter taste comprising adding at least one compound to a composition for ingestion by humans or animals at a concentration effective to alleviate or reduce the bitter taste associated with the composition, the at least one compound having the formula:

or a salt, hydrate, solvate or N-oxide thereof,

wherein Ar 6 and Ar 7 are, the same or different independently one from the other, a five-membered aryl, six-membered aryl, or a five-membered heteroaryl;

Alk is alkyl;

R 58 is H, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, acyl, substituted acyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl, or substituted heteroarylalkyl;

R 59 and R 60 are, the same or different independently one from the other, H, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, acyl, substituted acyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl, or substituted heteroarylalkyl, with the proviso that when one of R 59 or R 60 is H, then the other of R 59 or R 60 is not H; or

R 59 and R 60 , together with the atom to which the are attached, form a cycloalkyl, a substituted cycloalkyl, a cycloheteroalkyl, or substituted cycloheteroalkyl ring; or

R 58 and R 60 , together with the atoms to which the are attached, form a five-membered cycloheteroalkyl, six-membered cycloheteroalkyl, or substituted cycloheteroalkyl ring; or

or a salt, hydrate, solvate or N-oxide thereof,

wherein:

R 61 is H, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, acyl, substituted acyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl, or substituted heteroarylalkyl;

R 62 and R 63 are, the same or different independently one from the other, H, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, acyl, substituted acyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl, or substituted heteroarylalkyl, with the proviso that when one of R 62 or R 63 is H, then the other of R 62 or R 63 is not H,

or R 62 and R 63 , together with the atoms to which the are attached, form a cycloalkyl, a substituted cycloalkyl, a cycloheteroalkyl, or substituted cycloheteroalkyl ring; or

R 61 and R 62 , together with the atoms to which the are attached, form a five-membered cycloheteroalkyl, six-membered cycloheteroalkyl, or substituted cycloheteroalkyl ring; or

or a salt, hydrate, solvateor N-oxide thereof,

wherein:

R 64 and R 65 are the same or different independently one from the other, H, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, acyl, substituted acyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl, or substituted heteroarylalkyl, with the proviso that when one of R 64 or R 65 is H, then the other of R 64 or R 65 is not H,

or R 64 and R 65 , together with the atoms to which the are attached, form a cycloalkyl, a substituted cycloalkyl, a cycloheteroalkyl, or substituted cycloheteroalkyl ring;

each R 66 is independently hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, acyl, substituted acyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarvlalkyl, substituted heteroarylalkyl,—F, —Cl, —CN, —NO 2 , —OR 67 , —S(O) i R 67 , —NR 67 R 68 , —CONR 67 R 68 , —CO 2 R 67 , —NR 67 CO 2 R 68 , —NR 67 CONR 68 R 69 , —NR 67 CSNR 68 R 69 or —NR 67 C(═NH)NR 68 R 69 , —SO 2 NR 67 R 68 , —NR 67 SO 2 R 68 , —NR 67 SO 2 NR 68 R 69 , —B(OR 67 )(OR 68 ), —P(O)(OR 67 )(OR 68 ), or —P(O)(R 67 )(OR 68 ), wherein R 67 , R 68 , and R 69 are independently hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl, or substituted heteroarylalkyl or alternatively, R 67 and R 68 or R 68 and R 69 , together with the atoms to which they are attached, form a cycloheteroalkyl or substituted cycloheteroalkyl ring;

Ar 10 is an aryl or heteroaryl ring;

g is 0, 1, 2, 3, or 4;

h is 0, 1, 2, 3, or 4; and

i is 0, 1, or 2; or

or a salt, hydrate, solvate or N-oxide thereof,

wherein:

each R 70 is independently hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, acyl, substituted acyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl, substituted heteroarylalkyl, —F, —Cl, —CN, —NO 2 , —OR 67 , —S(O) i R 67 , —NR 67 R 68 , —CONR 67 R 68 , —CO 2 R 67 , —NR 67 CO 2 R 68 , —NR 67 CONR 68 R 69 , —NR 67 CSNR 68 R 69 or —NR 67 C(═NH)NR 68 R 69 , —SO 2 NR 67 R 68 , —NR 67 SO 2 R 68 , —NR 67 SO 2 NR 68 R 69 , —B(OR 67 )(OR 68 ), —P(O)(OR 67 )(OR 68 ), or —P(O)(R 67 )(OR 68 ), wherein R 67 , R 68 , and R 69 are independently hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl or substituted heteroarylalkyl or, alternatively, R 67 and R 68 or R 68 and R 69 , together with the atoms to which they are attached, form a cycloheteroalkyl or substituted cycloheteroalkyl ring;

j is 0, 1, or 2;

k is 0, 1, or 2; and

l is 0, 1, or 2;

with the proviso that j and k are not simultaneously both 0; or

or a salt, hydrate, solvate or N-oxide thereof.

2. The method of claim 1 , wherein the concentration of the at least one compound is from about 0.1 ppm to about 100 ppm.

3. The method of claim 1 , wherein the concentration of the at least one compound is from about 1 ppm to about 25 ppm.

4. The method of claim 1 , wherein the composition is a food, beverage, or medicament.

5. The method of claim 1 , wherein the composition contains bitter compounds that activate one or more of hT2R3, 7, 10, 14, 16, 44, 51, 55, 61, 63, 65, 71 and/or hT2R5, 9, 13, 54, 67, and 75.

6. The method of claim 1 , wherein the composition contains at least one bitter compound that activates multiple bitter receptors or which has an undetermined bitter receptor specificity.

7. The method of claim 1 , wherein the composition is a coffee or coffee flavored composition.

8. The method of claim 7 , wherein the composition comprises at least 2 compounds at least one of which is an hT2R8 antagonist and at least one of which is an hT2R14 antagonist.

9. The method of claim 7 , wherein the coffee or coffee flavored composition is an instant coffee or brewed coffee.

10. A method of identifying a conserved binding motif present in different human T2Rs comprising exposing the cell membrane of a cell to a compound having the formula:

or a salt, hydrate, solvate or N-oxide thereof,

wherein Ar 6 and Ar 7 are, the same or different independently one from the other, a five-membered aryl, six-membered aryl, or a five-membered heteroaryl;

Alk is alkyl;

R 58 is H, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, acyl, substituted acyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl, or substituted heteroarylalkyl;

R 59 and R 60 are, the same or different independently one from the other, H, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, acyl, substituted acyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl, or substituted heteroarylalkyl, with the proviso that when one of R 59 or R 60 is H, then the other of R 59 or R 60 is not H; or

R 59 and R 60 , together with the atom to which the are attached, form a cycloalkyl, a substituted cycloalkyl, a cycloheteroalkyl, or substituted cycloheteroalkyl ring; or

R 58 and R 60 , together with the atoms to which the are attached, form a five-membered cycloheteroalkyl, six-membered cycloheteroalkyl, or substituted cycloheteroalkyl ring; or

or a salt, hydrate, solvate or N-oxide thereof,

wherein:

R 61 is H, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, acyl, substituted acyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl, or substituted heteroarylalkyl;

R 62 and R 63 are the same or different independently one from the other, H, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, acyl, substituted acyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl, or substituted heteroarylalkyl, with the proviso that when one of R 62 or R 63 is H, then the other of R 62 or R 63 is not H,

or R 62 and R 63 , together with the atoms to which the are attached, form a cycloalkyl, a substituted cycloalkyl, a cycloheteroalkyl or substituted cycloheteroalkyl ring; or

R 61 and R 62 , together with the atoms to which the are attached, form a five-membered cycloheteroalkyl, six-membered cycloheteroalkyl, or substituted cycloheteroalkyl ring; or

or a salt, hydrate, solvateor N-oxide thereof,

wherein:

R 64 and R 65 are the same or different independently one from the other, H, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, acyl, substituted acyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl or substituted heteroarylalkyl, with the proviso that when one of R 64 or R 65 is H, then the other of R 64 or R 65 is not H,

or R 64 and R 65 , together with the atoms to which the are attached, form a cycloalkyl, a substituted cycloalkyl, a cycloheteroalkyl, or substituted cycloheteroalkyl ring;

each R 66 is independently hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, acyl, substituted acyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl, substituted heteroarylalkyl, —F, —Cl, —CN, —NO 2 , —OR 67 , —S(O) i R 67 , —NR 67 R 68 , —CONR 67 R 68 , —CO 2 R 67 , —NR 67 CO 2 R 68 , —NR 67 CONR 68 R 69 , —NR 67 CSNR 68 R 69 or —NR 67 C(═NH)NR 68 R 69 , —SO 2 NR 67 R 68 , —NR 67 SO 2 R 68 , —NR 67 SO 2 NR 68 R 69 , —B(OR 67 )(OR 68 ), —P(O)(OR 67 )(OR 68 ), or —P(O)(R 67 )(OR 68 ), wherein R 67 , R 68 , and R 69 are independently hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl, or substituted heteroarylalkyl or, alternatively, R 67 and R 68 or R 68 and R 69 , together with the atoms to which they are attached, form a cycloheteroalkyl or substituted cycloheteroalkyl ring;

Ar 10 is an aryl or heteroaryl ring;

g is 0, 1, 2, 3, or 4;

h is 0, 1, 2, 3, or 4; and

i is 0, 1, or 2; or

or a salt, hydrate, solvate or N-oxide thereof,

wherein:

each R 70 is independently hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, acyl, substituted acyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl, substituted heteroarylalkyl, —F, —Cl, —CN, —NO 2 , —OR 67 , —S(O) i R 67 , —NR 67 R 68 , —CONR 67 R 68 , —CO 2 R 67 , —NR 67 CO 2 R 68 , —NR 67 CONR 68 R 69 , —NR 67 CSNR 68 R 69 or —NR 67 C(═NH)NR 68 R 69 , —SO 2 NR 67 R 68 , —NR 67 SO 2 R 68 , —NR 67 SO 2 NR 68 R 69 , —B(OR 67 )(OR 68 ), —P(O)(OR 67 )(OR 68 ), or —P(O)(R 67 )(OR 68 ), wherein R 67 , R 68 , and R 69 are independently hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, arylalkyl, substituted arylalkyl, heteroalkyl, substituted heteroalkyl, heteroaryl, substituted heteroaryl, heteroarylalkyl or substituted heteroarylalkyl or, alternatively, R 67 and R 68 or R 68 and R 69 , together with the atoms to which they are attached, form a cycloheteroalkyl or substituted cycloheteroalkyl ring;

j is 0, 1, or 2;

k is 0, 1, or 2; and

l is 0, 1, or 2;

with the proviso that j and k are not simultaneously both 0; or

or a salt, hydrate, solvate or N-oxide thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 14, 2020
From: KARANEWSKI, DONALD; FOTSING, JOSEPH; TACHDJIAN, CATHERINE; ARELLANO, MELISSA
To: SENOMYX, INC.
Reel/Frame 054047/0385 →
MERGER Recorded Oct 14, 2020
From: SENOMYX, INC.
To: FIRMENICH INCORPORATED
Reel/Frame 054047/0461 →
Continuity (5)
Division 12656936 · Feb 19, 2010
Continuation In Part 12222918 · Aug 19, 2008
Provisional Application 60957129 · Aug 21, 2007
Provisional Application 61047187 · Apr 23, 2008
Related Publication 20120088796A1 · Apr 12, 2012